Letter: Limitations of studies to evaluate the significance of anti-tumour necrosis factor serum levels in Crohn's disease

Aliment Pharmacol Ther. 2014 Jul;40(1):120-1. doi: 10.1111/apt.12799.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / blood*
  • C-Reactive Protein / metabolism*
  • Crohn Disease / drug therapy*
  • Female
  • Gastrointestinal Agents / blood*
  • Humans
  • Infliximab
  • Male

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • C-Reactive Protein
  • Infliximab